1
|
Laurent A, Abdel-Sayed P, Scaletta C, Laurent P, Laurent E, Michetti M, de Buys Roessingh A, Raffoul W, Hirt-Burri N, Applegate LA. Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland. Bioengineering (Basel) 2021; 8:bioengineering8120221. [PMID: 34940374 PMCID: PMC8698568 DOI: 10.3390/bioengineering8120221] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2021] [Revised: 12/13/2021] [Accepted: 12/14/2021] [Indexed: 11/16/2022] Open
Abstract
Empirically studied by Dr. Brown-Séquard in the late 1800s, cytotherapies were later democratized by Dr. Niehans during the twentieth century in Western Switzerland. Many local cultural landmarks around the Léman Riviera are reminiscent of the inception of such cell-based treatments. Despite the discreet extravagance of the remaining heirs of "living cell therapy" and specific enforcements by Swiss health authorities, current interest in modern and scientifically sound cell-based regenerative medicine has never been stronger. Respective progress made in bioengineering and in biotechnology have enabled the clinical implementation of modern cell-based therapeutic treatments within updated medical and regulatory frameworks. Notably, the Swiss progenitor cell transplantation program has enabled the gathering of two decades of clinical experience in Lausanne for the therapeutic management of cutaneous and musculoskeletal affections, using homologous allogeneic cell-based approaches. While striking conceptual similarities exist between the respective works of the fathers of cytotherapy and of modern highly specialized clinicians, major and important iterative updates have been implemented, centered on product quality and risk-analysis-based patient safety insurance. This perspective article highlights some historical similarities and major evolutive differences, particularly regarding product safety and quality issues, characterizing the use of cell-based therapies in Switzerland over the past century. We outline the vast therapeutic potential to be harnessed for the benefit of overall patient health and the importance of specific scientific methodological aspects.
Collapse
Affiliation(s)
- Alexis Laurent
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, 1066 Epalinges, Switzerland; (A.L.); (P.A.-S.); (C.S.); (M.M.); (N.H.-B.)
- Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland;
- Applied Research Department, LAM Biotechnologies SA, 1066 Epalinges, Switzerland
- Manufacturing Department, TEC-PHARMA SA, 1038 Bercher, Switzerland
| | - Philippe Abdel-Sayed
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, 1066 Epalinges, Switzerland; (A.L.); (P.A.-S.); (C.S.); (M.M.); (N.H.-B.)
- DLL Bioengineering, Discovery Learning Program, STI School of Engineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland
| | - Corinne Scaletta
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, 1066 Epalinges, Switzerland; (A.L.); (P.A.-S.); (C.S.); (M.M.); (N.H.-B.)
| | - Philippe Laurent
- School of Pharmaceutical Sciences, University of Geneva, 1206 Geneva, Switzerland;
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1206 Geneva, Switzerland
- Private Practice, Pharmacie du Gros-de-Vaud SA, 1038 Bercher, Switzerland;
| | - Elénie Laurent
- Private Practice, Pharmacie du Gros-de-Vaud SA, 1038 Bercher, Switzerland;
| | - Murielle Michetti
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, 1066 Epalinges, Switzerland; (A.L.); (P.A.-S.); (C.S.); (M.M.); (N.H.-B.)
| | - Anthony de Buys Roessingh
- Children and Adolescent Surgery Service, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland;
- Lausanne Burn Center, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
| | - Wassim Raffoul
- Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland;
- Lausanne Burn Center, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
- Plastic, Reconstructive and Hand Surgery Service, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
| | - Nathalie Hirt-Burri
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, 1066 Epalinges, Switzerland; (A.L.); (P.A.-S.); (C.S.); (M.M.); (N.H.-B.)
- Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland;
| | - Lee Ann Applegate
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, 1066 Epalinges, Switzerland; (A.L.); (P.A.-S.); (C.S.); (M.M.); (N.H.-B.)
- Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland;
- Lausanne Burn Center, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
- Center for Applied Biotechnology and Molecular Medicine, University of Zurich, 8057 Zurich, Switzerland
- Oxford OSCAR Suzhou Center, Oxford University, Suzhou 215123, China
- Correspondence: ; Tel.: +41-21-314-35-10
| |
Collapse
|
2
|
Silina EV, Manturova NE, Litvitskiy PF, Stupin VA. Comparative Analysis of the Effectiveness of Some Biological Injected Wound Healing Stimulators and Criteria for Its Evaluation. Drug Des Devel Ther 2020; 14:4869-4883. [PMID: 33209017 PMCID: PMC7669517 DOI: 10.2147/dddt.s277047] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Accepted: 10/22/2020] [Indexed: 01/12/2023] Open
Abstract
PURPOSE To investigate the comparative effectiveness of certain biological injectable stimulants for the healing of skin wounds and criteria for its assessment. MATERIALS AND METHODS A comparative study of the effectiveness of mesenchymal stem cells (SC group), collagen (Collagen group), and deproteinized calf blood hemoderivative (DCBH group) was carried out using an acute wound model. Control wounds were injected with isotonic sodium chloride solution (Control group). A total of four groups (28 wounds per group) were included in the study. Aged male Wistar rats were used as experimental animals. A dynamic assessment of the wound areas and edges, microvasculature assessment via laser Doppler flowmetry, histological and morphometric analyses to determine the quantitative and qualitative fibroblasts composition, as well as the degree of newly synthesized collagen maturity, was conducted on days 0, 3, 7, and 14. RESULTS The administration of SCs provided a rapid but short-lasting effect, whereas the administration of collagen resulted in a delayed but long-lasting wound-healing effect. DCBH resulted in little to no effect. An increase in the perfusion volume of the wound edges accelerated the regeneration process, while the level of microcirculation did not affect the number and activity of fibroblasts. The wound healing acceleration, as well as the new collagen and stratified epithelium formation and maturation, was associated with the presence of a sufficient pool of mature and active fibroblasts in the wound, and not with the number of fibroblasts. CONCLUSION The present results clarify the action mechanisms of the studied drugs. In addition, the application purposes and different effects of each drug on the different wound healing phases were demonstrated. An assumption on the multi-component treatment advisability under the wound condition objective assessment possibility was made. Findings from this study may assist clinicians in making an informed transition to personalized wound management and achieve better clinical outcomes.
Collapse
Affiliation(s)
- Ekaterina Vladimirovna Silina
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow119991, Russia
| | - Natalia Evgenievna Manturova
- Department of Plastic and Reconstructive Surgery, Cosmetology and Cell Technologies, Pirogov Russian National Research Medical University, Moscow117997, Russia
| | - Petr Frantsevich Litvitskiy
- Department of Pathophysiology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow119991, Russia
| | | |
Collapse
|
3
|
Stupin V, Manturova N, Silina E, Litvitskiy P, Vasin V, Artyushkova E, Ivanov A, Gladchenko M, Aliev S. The Effect of Inflammation on the Healing Process of Acute Skin Wounds Under the Treatment of Wounds with Injections in Rats. J Exp Pharmacol 2020; 12:409-422. [PMID: 33154679 PMCID: PMC7608486 DOI: 10.2147/jep.s275791] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2020] [Accepted: 10/16/2020] [Indexed: 12/14/2022] Open
Abstract
PURPOSE To study the effects of inflammation on the healing process of rats' acute skin wounds during treatment with different injections. METHODS The study was carried out on Wistar rats, on which square wounds were simulated in the back region. Four groups of wounds were studied. On the day of the simulation (day 0), solutions of the drugs were injected into the wounds: an isotonic sodium chloride solution (Control group), mesenchymal stem cells (SC group), collagen (Collagen group), and a deproteinized hemoderivative of calf blood (DHB group). Within 2 weeks, the wound healing process was assessed by observing and calculating changes in the wound areas, temperatures, and epithelialization levels. On days 3, 7, and 14, wound tissue samples were taken for histological examination, morphological analysis of the healing process, and quantitative assessment of granulation layers' leukocyte infiltration. RESULTS A correlation between the process of inflammation and epithelization during the healing of skin wounds was established. The anti-inflammatory effect of SC injection on the wound edge tissues was determined, as well as the pro-inflammatory effect of DHB, and the absence of effects on the inflammation course under the collagen treatment. Compared to the control group, the transition from the exudative phase of inflammation to the proliferative phase was faster, as well was wound epithelialization in the SC and Collagen groups. A negative correlation between the level of tissue temperature in the center of wounds and their area were recorded, which intensified over time. CONCLUSION The severity and duration of the inflammation process during wound healing were ambiguous with the use of different injection treatments. This should compel clinicians to use different markers of drug therapy effectiveness during wound healing. Excessive leukocyte infiltration with a low temperature of wounds and a large scab were markers of delayed wound healing.
Collapse
Affiliation(s)
- Victor Stupin
- Department of Hospital Surgery No 1, Pirogov Russian National Research Medical University, Moscow, Russia
| | - Natalia Manturova
- Department of Plastic and Reconstructive Surgery, Cosmetology and Cell Technologies, Pirogov Russian National Research Medical University, Moscow, Russia
| | - Ekaterina Silina
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
| | - Petr Litvitskiy
- Department of Pathophysiology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
| | - Vitaly Vasin
- Department of Hospital Surgery No 1, Pirogov Russian National Research Medical University, Moscow, Russia
| | - Elena Artyushkova
- Research Institute of Experimental Medicine, Kursk State Medical University, Kursk, Russia
| | - Alexander Ivanov
- Department of Histology, Embryology, and Cytology, Kursk State Medical University, Kursk, Russia
| | - Mikhail Gladchenko
- Research Institute of Experimental Medicine, Kursk State Medical University, Kursk, Russia
| | - Salekh Aliev
- Department of Hospital Surgery No 1, Pirogov Russian National Research Medical University, Moscow, Russia
| |
Collapse
|